--- title: "Kuwait KDFC - Cybersecurity Submission Playbook" description: "How to submit a medical device to KDA in Kuwait: step-by-step route, evidence checklist, common rejections, and typical review timeline. Compared with FDA & g" lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "WebSite", "name": "The Medical Device Cybersecurity Crosswalk", "alternateName": "MDC Crosswalk", "url": "https://mdccrosswalk.com/", "description": "Compare FDA, EU MDR, MHRA, PMDA, NMPA, TGA, MFDS and Health Canada medical device cybersecurity requirements across 29 jurisdictions." }, { "@context": "https://schema.org", "@type": "Organization", "name": "MDC Crosswalk", "url": "https://mdccrosswalk.com/", "logo": "https://mdccrosswalk.com/favicon.png", "sameAs": [ "https://bluegoatcyber.com" ], "description": "An editorial reference comparing global medical-device cybersecurity regulations. Maintained by Blue Goat Cyber." }, { "@context": "https://schema.org", "@type": "Article", "headline": "Kuwait - MoH Medical Device Registration with GHC Reference Route", "description": "How to submit a medical device to KDA in Kuwait: step-by-step route, evidence checklist, common rejections, and typical review timeline. Compared with FDA & g", "author": { "@type": "Organization", "name": "MDC Crosswalk" }, "publisher": { "@type": "Organization", "name": "MDC Crosswalk" }, "image": "https://mdccrosswalk.lovable.app/favicon.png", "datePublished": "2024", "about": "Kuwait Drug and Food Control / Ministry of Health (KDFC)", "dateModified": "2026-07-16", "mainEntityOfPage": "https://mdccrosswalk.lovable.app/standards/kw" }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Is SBOM required for medical devices in Kuwait?", "acceptedAnswer": { "@type": "Answer", "text": "Not specified. Not required by KDFC today; CE/FDA SBOMs accepted as supporting evidence." } }, { "@type": "Question", "name": "What does KDA require for pre-market cybersecurity?", "acceptedAnswer": { "@type": "Answer", "text": "Reliance-based on reference-country approvals (FDA, CE, Health Canada, TGA, PMDA, MHRA). No standalone medical-device cybersecurity guideline; connected-device posture inherited from reference-country evidence." } }, { "@type": "Question", "name": "What are the post-market cybersecurity obligations under KDA?", "acceptedAnswer": { "@type": "Answer", "text": "Vigilance reporting to KDFC; CITRA handles ICT-incident coordination for connected devices in healthcare networks." } }, { "@type": "Question", "name": "What is the penalty for non-compliance with KDA cybersecurity rules?", "acceptedAnswer": { "@type": "Answer", "text": "Registration cancellation, market withdrawal, fines under MoH and CITRA orders." } }, { "@type": "Question", "name": "How much of my FDA cybersecurity package is reusable in Kuwait?", "acceptedAnswer": { "@type": "Answer", "text": "Roughly 80% - an editorial estimate based on overlapping evidence requirements (threat model, SBOM, security risk assessment, pen-test report)." } }, { "@type": "Question", "name": "Why do KDFC submissions get rejected for \"no local agent with valid moh licence\"?", "acceptedAnswer": { "@type": "Answer", "text": "Appoint a licensed local agent." } } ] }, { "@context": "https://schema.org", "@type": "HowTo", "name": "How to submit a medical device to KDA", "description": "Kuwait's MOH accepts GHTF approvals. Cybersecurity documentation is not separately mandated.", "totalTime": "3-6 months", "step": [ { "@type": "HowToStep", "position": 1, "name": "Appoint local representation", "text": "Most jurisdictions require a locally-established entity to hold the registration or act as authorised representative before submission." }, { "@type": "HowToStep", "position": 2, "name": "Reuse FDA or CE package as baseline", "text": "Adapt the cybersecurity subsection you already prepared for FDA or CE; regulators here typically accept the structure and ask for local labeling additions." }, { "@type": "HowToStep", "position": 3, "name": "Translate and localise", "text": "Local-language technical summary and labeling are usually mandatory; certified translation is safest." }, { "@type": "HowToStep", "position": 4, "name": "Submit + track queries", "text": "Respond to clarification rounds promptly; each unanswered question can add 30-90 days to the clock." } ] }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://mdccrosswalk.lovable.app/" }, { "@type": "ListItem", "position": 2, "name": "Standards" }, { "@type": "ListItem", "position": 3, "name": "Kuwait" } ] } ] --- [ The Crosswalk ](/) [Overview](/)[Playbook](/playbook)CompareReference [New Per-page social previews and this changelog ](/changelog "Per-page social previews and this changelog") Search⌘K 1. [Home ](/) 2. Standards 3. Kuwait KDA # ![Flag of Kuwait](/flags/kw.svg)Kuwait - KDA Guidance Last updated · 2024 Verified · 2026-07-16 MoH Medical Device Registration with GHC Reference Route Share Copy link X LinkedIn Email Sources verified · 2026-07-16 Cross-checked against KDFC circulars and GHC Centralized Registration Procedure scope. Authority Kuwait Drug and Food Control / Ministry of Health (KDFC) Enforced 2017 (KDFC medical device circulars) Legal framework Ministry of Health KDFC medical device registration circulars; Gulf Health Council (GHC) Centralized Registration Procedure available as a regional pathway across GCC. Cyber overlay relies on Kuwait Data Privacy Protection Regulation (CITRA, 2021) and CITRA's national cybersecurity strategy. FDA package reuse ~80% [Editorial estimate · how →](/methodology#fda-reuse) ## Scope All medical devices placed on the Kuwaiti market. GCC manufacturers may use the centralised GHC route covering KW, SA, AE, BH, OM, QA in a single dossier. Pre-market Reliance-based on reference-country approvals (FDA, CE, Health Canada, TGA, PMDA, MHRA). No standalone medical-device cybersecurity guideline; connected-device posture inherited from reference-country evidence. Post-market Vigilance reporting to KDFC; CITRA handles ICT-incident coordination for connected devices in healthcare networks. SBOM Not specified Not required by KDFC today; CE/FDA SBOMs accepted as supporting evidence. Vulnerability disclosure CITRA National CERT for ICT incidents; no medical-device-specific CVD requirement. Penalty Registration cancellation, market withdrawal, fines under MoH and CITRA orders. ## Unique requirements - 01 Kuwaiti authorised local agent - 02 Arabic-language IFU and labelling - 03 GHC route subject to per-country acceptance ## Highlights - GHC central route covers 6 GCC markets in one dossier - Reference-country reliance is the dominant route - CITRA data-protection overlay for connected devices ## Aligns with GHC Centralized Registration Procedure ISO 13485 IMDRF N60 (via reference countries) ## Timeline 1. 2017 KDFC medical device registration circulars 2. 2021 CITRA Data Privacy Protection Regulation in force 3. 2024 GHC centralised registration scope expanded ## Key documents [ Kuwait Ministry of Health - Drug & Food Control https://www.moh.gov.kw/en/ ](https://www.moh.gov.kw/en/)[ Gulf Health Council https://ghc.sa/en/ ](https://ghc.sa/en/) ## How to submit in Kuwait Playbook reviewed · 2026-07-16 Submission route MOH registration under Kuwaiti Medical Device Regulations Kuwait's MOH accepts GHTF approvals. Cybersecurity documentation is not separately mandated. [Authority portal](https://www.moh.gov.kw/) ### Step-by-step 1. Step 01 Appoint local representation Most jurisdictions require a locally-established entity to hold the registration or act as authorised representative before submission. 2. Step 02 Reuse FDA or CE package as baseline Adapt the cybersecurity subsection you already prepared for FDA or CE; regulators here typically accept the structure and ask for local labeling additions. 3. Step 03 Translate and localise Local-language technical summary and labeling are usually mandatory; certified translation is safest. 4. Step 04 Submit + track queries Respond to clarification rounds promptly; each unanswered question can add 30-90 days to the clock. ### Evidence checklist Item Level FDA equivalent Notes Cybersecurity documentation (baseline FDA or CE) Required SPDF Local authorised representative agreement Required — Local-language labeling and IFU Required — SBOM Recommended — Not mandatory but reduces clarification rounds. ### Common KDFC rejections No local agent with valid MOH licence Common Fix · Appoint a licensed local agent. ### Typical timeline End-to-end window: 3-6 months Phase 01 Local rep + dossier prep 2-4 months Phase 02 Regulatory review 3-6 months Phase 03 Approval + market entry 1-3 months [Previous ![Flag of Hong Kong](/flags/hk.svg)Hong Kong ](/standards/hk)[Next ![Flag of Taiwan](/flags/tw.svg)Taiwan ](/standards/tw) ## Related markets [![Flag of United Kingdom](/flags/gb.svg) United Kingdom ~80% FDA reuse ](/standards/uk)[![Flag of Taiwan](/flags/tw.svg) Taiwan ~80% FDA reuse ](/standards/tw)[![Flag of South Africa](/flags/za.svg) South Africa ~80% FDA reuse ](/standards/za)[![Flag of Malaysia](/flags/my.svg) Malaysia ~80% FDA reuse ](/standards/my) ## Frequently asked about Kuwait ### Is SBOM required for medical devices in Kuwait? Not specified. Not required by KDFC today; CE/FDA SBOMs accepted as supporting evidence. ### What does KDA require for pre-market cybersecurity? Reliance-based on reference-country approvals (FDA, CE, Health Canada, TGA, PMDA, MHRA). No standalone medical-device cybersecurity guideline; connected-device posture inherited from reference-country evidence. ### What are the post-market cybersecurity obligations under KDA? Vigilance reporting to KDFC; CITRA handles ICT-incident coordination for connected devices in healthcare networks. ### What is the penalty for non-compliance with KDA cybersecurity rules? Registration cancellation, market withdrawal, fines under MoH and CITRA orders. ### How much of my FDA cybersecurity package is reusable in Kuwait? Roughly 80% - an editorial estimate based on overlapping evidence requirements (threat model, SBOM, security risk assessment, pen-test report). Sponsored note · Blue Goat Cyber Submitting to KDA? Get a second pair of eyes before you file. Blue Goat Cyber has packaged cybersecurity evidence for Kuwait alongside 37 other markets. We'll tell you what to keep, what to rework, and what's missing, in 30 minutes. [Talk through your KDFC submission](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) The Crosswalk An independent reference for global medical device cybersecurity standards. A field guide for MedTech innovators and RA/QA teams charting an international path. Resource - [Comparison matrix](/compare) - [Global playbook](/playbook) - [Glossary](/glossary) - [FAQ](/faq) Sponsored by [Blue Goat Cyber ↗](https://bluegoatcyber.com) Editorially independent. Sponsorship keeps it free. © 2026 The Crosswalk. Not legal advice. Validate every requirement against current regulator publications.